This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Ravindra Kumar Garg, MD; Atul Agrawal, MD
Department of Neurology King George's Medical College Lucknow 226003, India

Arch Neurol. 1996;53(4):295.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

We read with interest the points raised against and in favor of medical treatment for cysticercosis.^1,2 As in Latin American countries, neurocysticercosis is a common neurological problem in India. Parenchymal neurocysticercosis is the most common cause of symptomatic epilepsy in our country. Subarachnoidal and ventricular and other forms of neurocysticercosis are relatively rare. Praziquantel is less commonly used by us because of the high cost and the potentially serious side effects.

After reaching the brain, cysticercus larva lodges itself in the parenchyma and subsequently passes through many stages.¹ Initially when viable larva develop into a small cyst, the patient is usually asymptomatic. Symptom (eg, seizures) develops only when the cyst is attacked by the host immune defense mechanisms. At this stage computed tomographic (CT) scan shows enhancing ring or nodular lesions with variable amounts of perifocal edema.³ In Indian patients with epilepsy, in whom single lesions are . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?